Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06480617

Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer

This is a large non-interventional observational bidirectional study planned to collect clinically relevant data and prognostic follow-up information of patients with cervical cancer who were seen at our center from 2010.01.01 to the end of this study.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

About this study

This study is a large-scale observational, bi-directional analytical study, which collects clinical data from patients with cervical cancer who have received treatment in the Department of Gynecologic Oncology of the First Hospital Affiliated to the University of Science and Technology of China (Anhui Provincial Hospital), including age, weight, BMI, menopausal status, history of the current disease, past history, specialized examinations, results of tests, results of genetic testing, pathology-related data, and information related to surgery, etc. The diagnosis, subsequent treatment, and follow-up of the subjects follow the routine clinical procedures of the clinical center. The diagnosis and subsequent treatment and follow-up of the subjects followed the routine clinical procedures of the clinical center, and the follow-up data of the enrolled patients were collected every six months: imaging, tumor markers, recurrence and treatment. And clinical big data analysis. Therefore, patients who meet the enrollment criteria can be included, and the sample size is based on the actual number of cases included.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years;
  • patients with a clear pathological diagnosis of cervical cancer;
  • all patients included in this study were diagnosed after 1 January 2010
  • Diagnosis or treatment of cervical cancer at the centres covered by this study;
  • exemption from informed consent or signing of an informed consent form.

Exclusion criteria

  • Loss of contact during the follow-up period for no apparent reason;
  • Discharged from the hospital for follow-up treatment at an outside institution with unknown treatment status;
  • The investigator considers the patient unsuitable for participation in this study;
  • cases where the clinical diagnosis is in doubt or unclear.

Treatment and study plan

Primary outcomes

  1. progression-free survival

    Time frame: 5 years

Secondary outcomes

  1. overall survival

    Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Anhui Provincial Hospital

Other Gov

Registry information

Official study title

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Jun 28, 2024
Registry last updated
Jun 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.